Zika Vaccines

The challenges in developing a safe and effective Zika virus vaccine include limiting side effects such as Guillain-Barré syndrome, a potential consequence of Zika virus infection. Discover the latest research on Zika vaccines here.

January 5, 2021
Open Access

Congenital abnormalities associated with Zika virus infection-Dengue as potential co-factor? A systematic review

PLoS Neglected Tropical Diseases
Stephanie PetzoldThomas Jaenisch
January 12, 2021
Open Access

Zika Virus-Induced Neuronal Apoptosis via Increased Mitochondrial Fragmentation

Frontiers in Microbiology
Shu YangWei Zheng
January 8, 2021
Open Access

Mapping the evolutionary landscape of Zika virus infection in immunocompromised mice

Virus Evolution
Katherine E E JohnsonKenneth A Stapleford
January 7, 2021
Preprint
Open Access

The use of mobile phones for the prevention and control of arboviral diseases: a scoping review

ResearchSquare
Maria Angelica CarrilloSilvia Runge Ranzinger
January 5, 2021

Risk of sexually transmitted Zika virus in a cohort of economically disadvantaged urban residents

The Journal of Infectious Diseases
Juan P Aguilar TiconaFederico Costa
December 28, 2020
Preprint
Open Access

Adaptation to host cell environment during experimental evolution of Zika virus

BioRxiv : the Preprint Server for Biology
V. GrassMarlène Dreux
January 5, 2021
Open Access

Adverse fetal and neonatal outcomes in pregnancies with confirmed Zika Virus infection in Rio de Janeiro, Brazil: A cohort study

PLoS Neglected Tropical Diseases
Juliana P SouzaMaria Elisabeth Moreira
January 6, 2021
Open Access

How Americans Make Sense of Two Novel Pandemics

Health Communication
Edward L FinkJoseph Woelfel
December 29, 2020
Open Access

Juntos: A Support Program for Families Impacted by Congenital Zika Syndrome in Brazil

Global Health, Science and Practice
Antony DuttineHannah Kuper
January 13, 2021
Open Access

A functional interaction between GRP78 and Zika virus E protein

Scientific Reports
Sarawut KhongwichitDuncan R Smith
January 2, 2021
Open Access

Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids

Viruses
Aleksandra PettkeMarjo-Riitta Puumalainen
December 17, 2020
Preprint
Open Access

ZIKV disrupts fetal outcome, placental ultrastructure and drug transporter expression in mice

BioRxiv : the Preprint Server for Biology
C. B. V. AndradeTania Maria Ortiga-Carvalho
January 13, 2021
Open Access

Pregnant Women Infected with Zika Virus Show Higher Viral Load and Immunoregulatory Cytokines Profile with CXCL10 Increase

Viruses
Elizabeth Camacho-ZavalaCésar González-Bonilla
December 18, 2020
Open Access

Mapping the cryptic spread of the 2015-2016 global Zika virus epidemic

BMC Medicine
Haoyang SunL Roman Carrasco
January 1, 2021
Case Report
Open Access

Zika Virus Infection in Tourists Travelling to Thailand: Case Series Report

Tropical Medicine and Infectious Disease
Natàlia RomaníAntoni Soriano-Arandes
January 14, 2021

The vulnerabilities of lives: Zika, women and children in Alagoas State, Brazil

Cadernos de saúde pública
Ilana G AmbrogiDebora Diniz
December 18, 2020
Open Access

Zika and dengue but not chikungunya are associated with Guillain-Barré syndrome in Mexico: A case-control study

PLoS Neglected Tropical Diseases
Israel GrijalvaArlette Areli Cervantes-Ocampo

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

© 2021 Meta ULC. All rights reserved
/feed-previews/zika-vaccines/b6d520d4-1507-485f-af59-f51b7826e3d0